BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36631026)

  • 21. Phylogenomic assessment of drug-resistant Mycobacterium tuberculosis strains from Beira, Mozambique.
    Namburete EI; Dippenaar A; Conceição EC; Feliciano C; Nascimento MMPD; Peronni KC; Silva WA; Ferro JJ; Harrison LH; Warren RM; Bollela VR
    Tuberculosis (Edinb); 2020 Mar; 121():101905. PubMed ID: 32063558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of whole-genome sequence to predict drug resistance of nine anti-
    Che Y; Lin Y; Yang T; Chen T; Sang G; Chen Q; He T
    Front Public Health; 2022; 10():956171. PubMed ID: 36062095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.
    Schleusener V; Köser CU; Beckert P; Niemann S; Feuerriegel S
    Sci Rep; 2017 Apr; 7():46327. PubMed ID: 28425484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
    Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of whole genome sequencing for multidrug resistant Mycobacterium tuberculosis isolates in a reference TB laboratory in New Zealand.
    Basu I; Bower JE; Roberts SA; Henderson G; Aung HL; Cook G; Lowe O; Newton S
    N Z Med J; 2018 Dec; 131(1487):15-22. PubMed ID: 30543607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible
    Hasan Z; Razzak SA; Kanji A; Shakoor S; Hasan R
    Int J Mycobacteriol; 2023; 12(2):179-183. PubMed ID: 37338481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
    Macedo R; Nunes A; Portugal I; Duarte S; Vieira L; Gomes JP
    Tuberculosis (Edinb); 2018 May; 110():44-51. PubMed ID: 29779772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole genome sequencing for the prediction of resistant tuberculosis strains from northern India.
    Saini A; Dadwal R; Yadav R; Kanaujia R; Aggarwal AN; Arora A; Sethi S
    Indian J Med Microbiol; 2024; 48():100537. PubMed ID: 38350525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing.
    Gliddon HD; Frampton D; Munsamy V; Heaney J; Pataillot-Meakin T; Nastouli E; Pym AS; Steyn AJC; Pillay D; McKendry RA
    Microbiol Spectr; 2021 Dec; 9(3):e0061021. PubMed ID: 34817282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan.
    Xiao YX; Liu KH; Lin WH; Chan TH; Jou R
    Sci Rep; 2023 Feb; 13(1):2540. PubMed ID: 36781938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the MeltPro TB assay and whole-genome sequencing assay for rapid molecular diagnosis of drug resistant tuberculosis in guangdong province.
    Yu M; Zhang C; Xu L; Peng K; Qiu H; Zhuo W; Zhao Y; Wu Z; Chen X; Chen Y; Liao Q; Huang Y; Wei W
    Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116128. PubMed ID: 38007912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
    Yakrus MA; Driscoll J; Lentz AJ; Sikes D; Hartline D; Metchock B; Starks AM
    J Clin Microbiol; 2014 Jun; 52(6):1932-7. PubMed ID: 24648563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Al-Hajoj S
    PLoS One; 2022; 17(10):e0276487. PubMed ID: 36264939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
    Wu SH; Xiao YX; Hsiao HC; Jou R
    Microbiol Spectr; 2022 Dec; 10(6):e0260522. PubMed ID: 36255328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium tuberculosis Lineages Associated with Mutations and Drug Resistance in Isolates from India.
    Shanmugam SK; Kumar N; Sembulingam T; Ramalingam SB; Selvaraj A; Rajendhiran U; Solaiyappan S; Tripathy SP; Natrajan M; Chandrasekaran P; Swaminathan S; Parkhill J; Peacock SJ; Ranganathan UDK
    Microbiol Spectr; 2022 Jun; 10(3):e0159421. PubMed ID: 35442078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
    PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
    Iwamoto T; Murase Y; Yoshida S; Aono A; Kuroda M; Sekizuka T; Yamashita A; Kato K; Takii T; Arikawa K; Kato S; Mitarai S
    PLoS One; 2019; 14(2):e0212798. PubMed ID: 30817803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.